Explore Publications

The corruption-prone country expects oil revenues to total $160 billion by 2025.

In two lawsuits, politically connected U.S. telecom companies have been accused of kickbacks to Former President Aristide and his associates.

The former chief accounting officer of Enron pleaded guilty today to a single felony charge of securities fraud and agreed to cooperate with federal prosecutors, giving a significant lift to the government's case against the two leading figures in the scandal over Enron's collapse.

Chronology of accounting practices and federal investigations of
Qwest Communications International Inc.:

2001:

--June 20: Morgan Stanley downgrades Qwest stock after analyst questions accounting practices. Qwest Chairman and Chief Executive Officer Joseph Nacchio later disputes the claim.

2002:

A former top executive of Qwest Communications International Inc on Wednesday pleaded guilty to wire fraud, avoiding a five-week trial that had been set to start on Tuesday.

Given the "significant" sum involved, the length of the audit process and the fact that $1.2 billion has been spent on the contract, the International Advisory and Monitoring Board called on Washington to "seek resolution" with the Iraqi Government on the possible improper use of resources.

The Board had consistently raised concerns about inadequate controls over Iraqi oil and other aspects of IDF's operation.

One of the paradoxes of the Kyoto Protocol on climate change is that companies in Russia and other Eastern European countries, which are among the world's largest producers of greenhouse gases, are poised to earn hundreds of millions of dollars through trading their rights to release carbon dioxide into the air.

Evo Morales, an Aymara Indian who grew up in childhood poverty, has won the Bolivian presidential elections. He is part of a wave of leftists taking power in Latin America and challenging multinational corporations.

The Food and Drug Administration yesterday released a warning letter it sent to the Guidant Corporation, restricting the ability of the company to win approval for some new medical products. In the letter, sent a week ago, the agency said Guidant, the heart device maker, had not fully responded to its concerns about manufacturing procedures at the company's biggest plant.